Citius Oncology (CTOR) Other Non-Current Liabilities (2024 - 2026)
Citius Oncology (CTOR) posted quarterly Other Non-Current Liabilities of $559015.0 for Q1 2026, little changed year-over-year from $559015.0 in Q1 2025, and little changed quarter-over-quarter from $559015.0 in Q4 2025.
Citius Oncology (CTOR) Other Non-Current Liabilities (2024 - 2026) Analysis & Trends
Citius Oncology (CTOR) has reported Other Non-Current Liabilities for 3 consecutive years, with $559015.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Liabilities changed 0.0% year-over-year to $559015.0; the TTM figure through Mar 2026 stood at $559015.0 (changed 0.0% YoY), while the FY2025 annual figure was $559015.0, changed N/A from the prior year.
- Other Non-Current Liabilities steadied at $559015.0 in Q1 2026 per CTOR's latest filing, from $559015.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $559015.0 in Q4 2024 and bottomed at $559015.0 in Q4 2024.
- Historically, Other Non-Current Liabilities has averaged $559015.0 across 3 years, with a median of $559015.0 in 2024.
- On a YoY basis, Other Non-Current Liabilities climbed as much as 0.0% in 2025 and fell as far as 0.0% in 2025.
- Citius Oncology's Other Non-Current Liabilities stood at $559015.0 in 2024, then changed by 0.0% to $559015.0 in 2025, then changed by 0.0% to $559015.0 in 2026.
- Business Quant data shows CTOR's Other Non-Current Liabilities at $559015.0 in Q1 2026, $559015.0 in Q4 2025, and $559015.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Citius Oncology | 81.12 Mn | 81.12 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 559,015.00 |
| Dec 31, 2025 | 559,015.00 |
| Sep 30, 2025 | 559,015.00 |
| Jun 30, 2025 | 559,015.00 |
| Mar 31, 2025 | 559,015.00 |
| Dec 31, 2024 | 559,015.00 |